These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 174825)

  • 41. Adoption of a new Haemophilus influenzae type b vaccine recommendation.
    Freed GL; Konrad TR; DeFriese GH; Lohr JA
    Am J Dis Child; 1993 Feb; 147(2):124-8. PubMed ID: 8427227
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of Bordetella pertussis as an adjuvant to antibody production.
    FARTHING JR
    Br J Exp Pathol; 1961 Dec; 42(6):614-22. PubMed ID: 13891726
    [No Abstract]   [Full Text] [Related]  

  • 43. Some growth requirements of Haemophilus influenzas and Haemophilus pertussis.
    BRUMFITT W
    J Pathol Bacteriol; 1959 Jan; 77(1):95-100. PubMed ID: 13621337
    [No Abstract]   [Full Text] [Related]  

  • 44. Lack of immune response to Hemophilus influenzae: immune paralysis or immaturity?
    South MA
    J Pediatr; 1972 Feb; 80(2):348-50. PubMed ID: 4536662
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
    Halsey NA; Johansen TL; Bowman LC; Glode MP
    Infect Immun; 1983 Mar; 39(3):1196-200. PubMed ID: 6601621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
    Chu C; Schneerson R; Robbins JB; Rastogi SC
    Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Group B streptococci in human disease.
    Patterson MJ; El Batool Hafeez A
    Bacteriol Rev; 1976 Sep; 40(3):774-92. PubMed ID: 791241
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.
    Baker PJ; Stashak PW; Prescott B
    Appl Microbiol; 1969 Mar; 17(3):422-6. PubMed ID: 4388600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody responses to a combination vaccine against Haemophilus influenzae type b, diphtheria, pertussis, and tetanus.
    Moxon ER; Anderson P; Smith DH; Blanca Adrianzen T; Graham GG; Baker RS
    Bull World Health Organ; 1975; 52(1):87-90. PubMed ID: 174825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.